David Wilson - Cencora Lead Independent Director
| COR Stock | USD 249.69 1.24 0.50% |
Director
Dr. David A. Wilson is Lead Independent Director of CoreSite Realty Corporationration Mr. Wilson has served as a director since September 2010. Mr. Wilson served as President and Chief Executive Officer of the Graduate Management Admission Council from 1995 until his retirement in December 2013. The Council is the owner of the Graduate Management Admission Test, the GMAT. Prior to 1995, he was a Managing Partner and National Director for Professional Development at Ernst Young LLP, a public accounting firm. From 1968 to 1978, Mr. Wilson held faculty positions at the University of Texas at Austin, where he was awarded tenure, and at Harvard Business School. Mr. Wilson completed his undergraduate studies at Queen University in Canada, received his M.B.A. at the University of California, Berkeley, and received his doctorate at the University of Illinois. He is a Chartered Accountant in Canada and a Certified Public Accountant in the United States. Mr. Wilson served on the board of directors of Laureate Education, Inc., a company which provides access to highquality, innovative institutions of higher education, from 2002 to 2007, and of Terra Industries, Inc., a producer and marketer of nitrogen products for the agricultural and industrial markets, from 2009 to 2010. At Laureate, he chaired the Audit Committee and served as a member of the Nominating and Governance Committee and the Conflicts Committee. He served on the Audit Committee of Terra. He has served on the Worldwide Board of Junior Achievement, the Conseil dAdministration de la Confrrie de la Chane des Rtisseurs and The Wolf Trap Foundation since 2016.
| Age | 78 |
| Tenure | 8 years |
| Address | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 |
| Phone | 610 727 7000 |
| Web | https://www.cencora.com |
David Wilson Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Wilson against Cencora stock is an integral part of due diligence when investing in Cencora. David Wilson insider activity provides valuable insight into whether Cencora is net buyers or sellers over its current business cycle. Note, Cencora insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cencora'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Wilson over a year ago Acquisition by David Wilson of 15401 shares of KeyCorp subject to Rule 16b-3 | ||
David Wilson over a year ago Acquisition by David Wilson of 118736 shares of Inspired Entertainment subject to Rule 16b-3 | ||
David Wilson over a year ago KeyCorp exotic insider transaction detected | ||
David Wilson over a year ago Acquisition by David Wilson of 209 shares of RESPIRERX PHARMACEUTICALS subject to Rule 16b-3 |
Cencora Management Efficiency
The company has Return on Asset of 0.031 % which means that on every $100 spent on assets, it made $0.031 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.0912 %, implying that it generated $2.0912 on every 100 dollars invested. Cencora's management efficiency ratios could be used to measure how well Cencora manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cencora's Return On Tangible Assets are relatively stable compared to the past year. As of 11/28/2024, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop 0.15. At this time, Cencora's Intangibles To Total Assets are relatively stable compared to the past year. As of 11/28/2024, Return On Assets is likely to grow to 0.02, while Net Tangible Assets are likely to drop (12.7 B).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| George Sutton | Glacier Bancorp | 72 | |
| Annie Goodwin | Glacier Bancorp | 62 | |
| Matthew Barger | Artisan Partners Asset | 62 | |
| Jennifer Barbetta | Artisan Partners Asset | 47 | |
| Sherry Cladouhos | Glacier Bancorp | 65 | |
| Stephanie DiMarco | Artisan Partners Asset | 62 | |
| Kiran MazumdarShaw | Infosys Ltd ADR | 67 | |
| U Rao | Infosys Ltd ADR | 58 | |
| Michael Gibbs | Infosys Ltd ADR | 63 | |
| Douglas McBride | Glacier Bancorp | 68 | |
| David Boyles | Glacier Bancorp | 70 | |
| James English | Glacier Bancorp | 75 | |
| Punita Sinha | Infosys Ltd ADR | 57 | |
| Jeffrey Joerres | Artisan Partners Asset | 61 | |
| Tally Porat | Sapiens International | N/A | |
| Michael Harris | Getty Images Holdings | 43 | |
| Tench Coxe | Artisan Partners Asset | 62 | |
Management Performance
| Return On Equity | 2.09 | ||||
| Return On Asset | 0.031 |
Cencora Leadership Team
Elected by the shareholders, the Cencora's board of directors comprises two types of representatives: Cencora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cencora. The board's role is to monitor Cencora's management team and ensure that shareholders' interests are well served. Cencora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cencora's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PharmD Mauch, CEO, President | ||
| Michael Millegan, Independent Director | ||
| James Cleary, Executive CFO | ||
| Elizabeth JD, Executive Officer | ||
| Bennett Murphy, Senior Relations | ||
| Maile Kaiser, Senior Vice President of Sales | ||
| John Chou, Ex CEO | ||
| Pawan Verma, Chief VP | ||
| Jeffrey Finnin, Chief Financial Officer | ||
| Derek McCandless, Senior Vice President - Legal, General Counsel, Secretary | ||
| David Wilson, Lead Independent Director | ||
| Elizabeth Campbell, Executive Officer | ||
| Silvana Battaglia, Executive Officer | ||
| Leslie Donato, Executive Officer | ||
| Lazarus Krikorian, Chief VP | ||
| Robert Stuckey, Independent Chairman of the Board | ||
| J Quinn, VP Treasurer | ||
| James Attwood, Independent Director | ||
| John Thompson, Independent Director | ||
| Aleksandra Krusko, Senior Vice President Information Technology | ||
| Steven Collis, President Chairman | ||
| Anthony Hatzenbuehler, Senior Vice President Data Center Operations | ||
| Jean Bua, Independent Director | ||
| Michael Koehler, Independent Director | ||
| Paul Szurek, President, Chief Executive Officer, Director | ||
| Ann Anaya, Senior Officer | ||
| Richard Tremonte, EVP Pharmaceuticals | ||
| Gina Clark, Executive Officer | ||
| Juan Font, Senior Vice President - General Management | ||
| Jennifer Dubas, Senior Officer | ||
| Brian Warren, Senior Vice President - Development and Product Engineering | ||
| Kelly Chambliss, Independent Director | ||
| Kathy Gaddes, Ex Officer | ||
| Patricia Higgins, Independent Director | ||
| Steven Smith, Sr. VP of Sales and Marketing | ||
| RPh Nightengale, President Pharmacy |
Cencora Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cencora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.09 | ||||
| Return On Asset | 0.031 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 49.28 B | ||||
| Shares Outstanding | 196.01 M | ||||
| Shares Owned By Insiders | 10.53 % | ||||
| Shares Owned By Institutions | 91.91 % | ||||
| Number Of Shares Shorted | 9.99 M | ||||
| Price To Earning | 82.16 X |
Pair Trading with Cencora
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cencora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cencora will appreciate offsetting losses from the drop in the long position's value.Moving together with Cencora Stock
Moving against Cencora Stock
| 0.7 | DRIO | DarioHealth Corp | PairCorr |
| 0.52 | EKSO | Ekso Bionics Holdings | PairCorr |
| 0.46 | VERO | Venus Concept | PairCorr |
The ability to find closely correlated positions to Cencora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cencora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cencora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cencora to buy it.
The correlation of Cencora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cencora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cencora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cencora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cencora Stock Analysis
When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.